- Home
- A-Z Publications
- Recent Advances in Drug Delivery and Formulation
- Previous Issues
- Volume 17, Issue 4, 2023
Recent Advances in Drug Delivery and Formulation - Volume 17, Issue 4, 2023
Volume 17, Issue 4, 2023
-
-
Gum-based Nanoparticles Targeting for Colon Rectal Cancer: Latest Research and Patents
Authors: Shilpi Shakya, Ritesh K. Tiwari and Arti GuptaColorectal disease is the third most prevelant cancer in both men and women, with an expected 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer as per American Cancer Society. Targeted medicine delivery is vital in the treatment of colon disorders because it delivers long-term therapeutic results with little side effects. Natural polymer is biocompatible and biodegradable, which enables safety, Read More
-
-
-
Current Strategy of Monoclonal Antibody: Development, Cloning, Formulation and Drug Delivery
The development of Monoclonal antibodies (mAbs) has also allowed researchers to understand the complexity of diseases better and find new treatments for difficult-to-treat conditions. Using mAbs, researchers can identify and target specific molecules in the body involved in the disease process. This has allowed for a more targeted treatment approach, which has resulted in improved outcomes for many patients. This hy Read More
-
-
-
Development of Novel Spray-dried Microparticles to Treat Cystic Fibrosis: A Tri-drug Approach
Authors: Vinayak D. Kabra, Swaroop R. Lahoti and Vrashabh V. SugandhiBackground: Cystic fibrosis is the predominant autosomal recessive disorder known to reduce life expectancy. Research findings indicate that around 60 to 70% of adult individuals with this condition carry infections of Pseudomonas aeruginosa.Objective: The ongoing research investigates the potential synergy of merging ivacaftor and ciprofloxacin to address bacterial infections.Methods: The two drugs were spray-dried int Read More
-
-
-
Development of Niosomal Vesicles Loaded Mometasone Furoate Gel for Transdermal Delivery and its Evaluation
Authors: Bhushan R. Rane, Pushkar Y. Chavan, Nidhi S. Kate and Ashish S. JainBackground: Mometasone Furoate (MF) is a corticosteroid (glucocorticoid) used to treat eczema, psoriasis, allergies, and rash on the skin; also used to reduce itching, redness, and swelling (inflammation). It has been reported that the bioavailability of MF is less than 11% when given via the nasal route. Encapsulating the drug in niosomes can improve the active pharmaceutical ingredient's bioavailability by enhancing both physical Read More
-
-
-
Tofacitinib Citrate-loaded Nanoparticle Gel for the Treatment of Alopecia Areata: Response Surface Design, Formulation and In vitro-in Vivo Characterization
Authors: Mounika Kuchukuntla, Venkatesan Palanivel and Ananthula MadhubabuObjective: The purpose of this research was to optimize the design and construction of nanoparticle gel (TFN-NPs) loaded with tofacitinib citrate (TFN) using poly lactic co glycolic acid (PLGA).Method: PLGA (A) as the polymer, polyvinyl alcohol (PVA) (B) as the stabilizer and stirring speed (C) as independent variables were used. TFN-NPs were prepared using single emulsion-solvent evaporation. Box Behnken Design (BBD) was us Read More
-
Volumes & issues
Most Read This Month
Article
content/journals/raddf
Journal
10
5
false
en
